6630wk81 Psycho pharmacologic Treatments
Assignment 1: Short Answer Assessment
As a psychiatric nurse practitioner, you will likely encounter patients who suffer from various mental health disorders. Not surprisingly, ensuring that your patients have the appropriate psycho pharmacologic treatments will be essential for their overall health and well-being. The psycho pharmacologic treatments you might recommend for patients may have potential impacts on other mental health conditions and, therefore, require additional consideration for positive patient outcomes. For this Assignment, you will review and apply your understanding of psycho pharmacologic treatments for patients with multiple mental health disorders.6630wk81 Psycho pharmacologic Treatments
To Prepare
To complete:
Address the following Short Answer prompts for your Assignment. Be sure to include references to the Learning Resources for this week. I would also encourage you to use External Resources.
In 3 or 4 sentences, explain the appropriate drug therapy for a patient who presents with MDD and a history of alcohol abuse. Which drugs are contraindicated, if any, and why? Be specific. What is the timeframe that the patient should see resolution of symptoms?
List 4 predictors of late onset generalized anxiety disorder.
List 4 potential neurobiology causes of psychotic major depression.
An episode of major depression is defined as a period of time lasting at least 2 weeks. List at least 5 symptoms required for the episode to occur. Be specific.6630wk81 Psycho pharmacologic Treatments
List 3 classes of drugs, with a corresponding example for each class, that precipitate insomnia. Be specific.
A combined therapy of naltrexone with sertraline antidepressant can be effective in treating a patient suffering from MDD with alcohol use history. Naltrexone is the first-line of alcohol abuse treatment while sertraline antidepressant affects the brain chemicals altered by depression (Carton et al., 2018). sertraline antidepressant interacts with eliglustat, flibanserin, isocarboxazid, lomitapide, phenelzine, pimozide, procarbazine, selegiline, thioridazine, tranylcypromine while naltrexone is contraindicated to narcotic drugs and diarrhea medications (Carton et al., 2018). Resolution of symptoms can be seen between 4-6 weeks.
References
Carton, L., Pignon, B., Baguet, A., Benradia, I., Roelandt, J. L., Vaiva, G., … & Rolland, B. (2018). Influence of comorbid alcohol use disorders on the clinical patterns of major depressive disorder: a general population-based study. Drug and alcohol dependence, 187, 40-47.
Croarkin, P. E. (2018). Indexing the neurobiology of psychotic depression with resting state connectivity: Insights from the STOP-PD study. EBioMedicine, 37, 32-33.
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018). Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA psychiatry, 75(4), 336-346.
Zhang, X., Norton, J., Carrière, I., Ritchie, K., Chaudieu, I., & Ancelin, M. L. (2019). Risk factors for late-onset generalized anxiety disorder: results from a 12-year prospective cohort (the ESPRIT study). Translational psychiatry, 5(3), e536. https://doi.org/10.1038/tp.2015.31 6630wk81 Psycho pharmacologic Treatments